Medicare Enrolled

Dr. Dennie Schultheis, MD

Family Medicine · Sacramento, CA
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Low-engagement
3946 NORWOOD AVE, Sacramento, CA 95838
9167375555
In practice since 2005 (20 years)
NPI: 1093713240 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schultheis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schultheis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schultheis

Dr. Dennie Schultheis is a family medicine specialist in Sacramento, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schultheis performed 54 Medicare services across 50 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schultheis received a total of $737 from 15 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schultheis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 54 Medicare services $737 industry payments

Medicare Practice Summary

Medicare Utilization ↗
54
Medicare services
Bottom 11% in CA for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
50
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
 22 $3 $10
COVID-19 immunoassay detection test
A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation.
 17 $41 $75
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
 15 $10 $26
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$737
Total received (2019-2024)
Avg $123/year across 6 years
Top 31% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$737 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$134
2023
$274
2022
$177
2021
$16
2020
$41
2019
$95

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$67
Phathom Pharmaceuticals, Inc.
$29
PFIZER INC.
$23
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 88.5% of 2024 payments
All-time payments by company (2019-2024) ›
Bayer Healthcare Pharmaceuticals Inc.
$111
Novo Nordisk Inc
$99
GlaxoSmithKline, LLC.
$73
Dexcom, Inc.
$67
PFIZER INC.
$60
Biohaven Pharmaceutical Holding Company Ltd.
$58
AstraZeneca Pharmaceuticals LP
$45
Amgen Inc.
$45
Scilex Pharmaceuticals Inc.
$39
Phathom Pharmaceuticals, Inc.
$29
Lilly USA, LLC
$25
Xeris Pharmaceuticals, Inc.
$24
Hologic Sales and Service, LLC
$24
Merck Sharp & Dohme LLC
$21
Merck Sharp & Dohme Corporation
$19
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · APTIMA · Aimovig · BEXSERO · BOOSTRIX · COMIRNATY · Dexcom G6 Transmitter · EMGALITY · Enbrel · FASENRA · GARDASIL 9 · GVOKE HYPOPEN · Kerendia · NURTEC ODT · Ozempic · PNEUMOVAX 23 · PREVNAR 20 · Rybelsus · SYMBICORT · Saxenda · TRELEGY ELLIPTA · TRULICITY · VOQUEZNA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Sacramento?
Compare family medicine physicians in the Sacramento area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,009
Per 100K population
63.7
County median income
$88,724
Nearest hospital
SACRAMENTO BEHAVIORAL HEALTHCARE HOSPITAL, LLC
2.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schultheis is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schultheis experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Schultheis performed 22 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schultheis receive payments from pharmaceutical companies?
Yes. Dr. Schultheis received a total of $737 from 15 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schultheis's costs compare to other family medicine physicians in Sacramento?
Dr. Schultheis's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schultheis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Sacramento
Browse family medicine physicians in Sacramento ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →